Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Clarus Therapeutics (NASDAQ:CRXT – Get Rating) and SOPHiA GENETICS (NASDAQ:SOPH – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability. Analyst Ratings This is a summary of current ratings […]
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT – Get Rating) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 2,780,000 shares, a growth of 433.3% from the May 15th total of 521,300 shares. Currently, 10.6% of the company’s shares are sold short. Based on an […]